Literature DB >> 9422333

Regulation of neutrophils in ulcerative colitis by colonic factors: a possible mechanism of neutrophil activation and tissue damage.

C E Robinson1, V Kottapalli, M D'Astice, J Z Fields, D Winship, A Keshavarzian.   

Abstract

The mucosal injury of active ulcerative colitis (UC) could involve enhanced migration and activation of neutrophils (PMNs). Because, in vitro, PMNs from patients with UC appear normal and are not therefore a likely cause for the enhancements, we hypothesized an abnormal colonic milieu. We previously found that factors in the UC colonic milieu markedly increase production of reactive oxygen species (ROS) by control PMNs. We now hypothesize that these factors also regulate PMN surface integrins, that regulation of UC PMNs is different than that of control PMNs, and that the integrin regulation is consistent with the ROS regulation. Using rectal dialysis, we sampled the colonic milieu in patients with active UC, in patients with inactive UC, and in control subjects. We monitored a key PMN adhesion molecule, CD11b. When control PMNs were tested, active UC rectal dialysate was almost as effective (+115%) as N-formyl-methionyl-leucyl-phenylalanine (+132%) in up-regulating CD11b. When inactive UC PMNs were tested, baseline CD11b was 50% higher than that for control PMNs. In contrast, rectal dialysates failed to up-regulate CD11b of inactive UC PMNs and in fact down-regulated CD11b. Preincubating control PMNs with UC rectal dialysates converted their CD11b response to PMN activators from up-regulation to down-regulation, mimicking inactive UC PMNs. Changes in intracellular calcium levels paralleled these changes in CD11b. Rectal dialysate-induced changes in both CD11b and calcium paralleled our previous findings on rectal dialysate-induced changes in ROS production. Thus the net overall effect of factors in the colonic milieu is a consistent and predictable regulation of PMN function--proinflammatory in UC, anti-inflammatory in control subjects. These factors may be a critical part of the pathophysiology of UC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422333     DOI: 10.1016/s0022-2143(97)90109-8

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Eosinophil granulocytes are activated during the remission phase of ulcerative colitis.

Authors:  M Lampinen; A Rönnblom; K Amin; G Kristjansson; F Rorsman; P Sangfelt; B Säfsten; M Wagner; A Wanders; O Winqvist; M Carlson
Journal:  Gut       Date:  2005-05-10       Impact factor: 23.059

Review 2.  Heterogeneity across the murine small and large intestine.

Authors:  Rowann Bowcutt; Ruth Forman; Maria Glymenaki; Simon Richard Carding; Kathryn Jane Else; Sheena Margaret Cruickshank
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

3.  Serum Carbonic Anhydrase 1 is a Biomarker for Diagnosis of Human Schistosoma mansoni Infection.

Authors:  Manal Ibrahim Kardoush; Brian J Ward; Momar Ndao
Journal:  Am J Trop Med Hyg       Date:  2017-04       Impact factor: 2.345

Review 4.  Interplay between DNA repair and inflammation, and the link to cancer.

Authors:  Dawit Kidane; Wook Jin Chae; Jennifer Czochor; Kristin A Eckert; Peter M Glazer; Alfred L M Bothwell; Joann B Sweasy
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-13       Impact factor: 8.250

5.  Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer.

Authors:  Aswin Mangerich; Charles G Knutson; Nicola M Parry; Sureshkumar Muthupalani; Wenjie Ye; Erin Prestwich; Liang Cui; Jose L McFaline; Melissa Mobley; Zhongming Ge; Koli Taghizadeh; John S Wishnok; Gerald N Wogan; James G Fox; Steven R Tannenbaum; Peter C Dedon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

6.  Effects of iron deprivation or chelation on DNA damage in experimental colitis.

Authors:  M Barollo; R D'Incà; M Scarpa; V Medici; R Cardin; W Fries; I Angriman; G C Sturniolo
Journal:  Int J Colorectal Dis       Date:  2004-04-06       Impact factor: 2.571

7.  Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide.

Authors:  A Farhadi; A Keshavarzian; L R Fitzpatrick; E Mutlu; Y Zhang; A Banan
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

8.  Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis.

Authors:  Marta Dabek; Laurent Ferrier; Richard Roka; Krisztina Gecse; Anita Annahazi; Jacques Moreau; Jean Escourrou; Christel Cartier; Gilles Chaumaz; Mathilde Leveque; Afifa Ait-Belgnaoui; Tibor Wittmann; Vassilia Theodorou; Lionel Bueno
Journal:  Am J Pathol       Date:  2009-06-15       Impact factor: 4.307

9.  Identification of potential plasma protein biomarkers for bipolar II disorder: a preliminary/exploratory study.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Ru-Band Lu; Liang-Jen Wang; Sung-Chou Li; Chi-Ying Tu; Cheng-Ho Chang; Yung-Chih Chiang; Kuo-Wang Tsai
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

10.  Plasma BDNF and Cytokines Correlated with Protein Biomarkers for Bipolar II Disorder.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Ru-Band Lu; Liang-Jen Wang; Cheng-Ho Chang; Yung-Chih Chiang; Chih-Chuan Pan; Kuo-Wang Tsai
Journal:  J Pers Med       Date:  2021-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.